HELP · Helus Pharma Inc
United States · RS rating 87 · As of 2026-10-14
| Price | 10.38 USD |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 87 / 11 / 96 / 93 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 31 / 40 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +28.1% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +26.0% |
| Market cap (USD) | $286.9M |